FDA approves 1st of 4-part Cohera Medical TissuGlue PMA program

Wed, 10/31/2012 - 9:45am
Mass Device

Cohera Medical wins FDA approval for the 1st of 4 modules for its premarket approval of the TissuGlu surgical adhesive system.

Cohera Medical logo

Cohera Medical landed the 1st of 4 FDA approvals for its TissuGlu surgical adhesive system, which is used as an internal adhesive in large flap procedures, such as "tummy-tuck" surgery.

Cohera earlier this year came to an agreement with the FDA to conduct a modular approach to filing its pre-market approval application, and submitted its 1st module according to plan.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.